1. Measurement of residual radioactivity in postoperative inpatients with differentiated thyroid carcinoma after 131I treatment using robot
Qianjing JI ; Ruiqing DI ; Weina CHEN ; Jing PAN ; Yang LIU ; Hui SHANG ; Gege KONG ; Yaoshan YE ; Bing CHENG ; Xiangzhou LI ; Xin WEN ; Xingmin HAN
Chinese Journal of Nuclear Medicine and Molecular Imaging 2019;39(10):601-605
Objective:
To evaluate the residual radioactivity after 131I treatment in postoperative inpatients with differentiated thyroid carcinoma (DTC) using service robot in nuclear medicine ward, and assess the time for patients to be released from isolation.
Methods:
From September 2017 to June 2018, 297 patients (94 males, 203 females, age: 19-80 years) with DTC who underwent 131I treatment after surgery were included. According to the purpose of treatment and the prescription dosage of 131I, patients were divided into 8 groups: 4 groups accepted 131I remnant ablation therapy (RAT) with different dosages, which were 3 700 MBq (RAT1,